iNtRON Biotechnology Inc
KOSDAQ:048530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Barrick Gold Corp
XETRA:ABR
|
CA |
|
S
|
Shopify Inc
LSE:0VHA
|
CA |
iNtRON Biotechnology Inc
Total Equity
iNtRON Biotechnology Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
i
|
iNtRON Biotechnology Inc
KOSDAQ:048530
|
Total Equity
₩69.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
Celltrion Inc
KRX:068270
|
Total Equity
₩17.2T
|
CAGR 3-Years
61%
|
CAGR 5-Years
39%
|
CAGR 10-Years
27%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Total Equity
₩1.8T
|
CAGR 3-Years
1%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Equity
₩66.4B
|
CAGR 3-Years
113%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Equity
₩445.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
28%
|
CAGR 10-Years
28%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Equity
₩154.7B
|
CAGR 3-Years
31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
iNtRON Biotechnology Inc
Glance View
iNtRON Biotechnology, Inc. is a Korea-based company principally engaged in the biotechnology industry. The Company operates its business through two main divisions: genetic reagent division and molecular diagnostics division. Its genetic reagent division is involved in the research and development of reagents, which are under the brand names of Maxime and pLUG for life science research. Its molecular diagnostics division is engaged in the development and production of nucleic acid tester for infectious diseases. It also engages in the operation of veterinary antibiotic alternative business and new biopharmaceuticals development business. The Company distributes its products within domestic market and to overseas markets.
See Also
What is iNtRON Biotechnology Inc's Total Equity?
Total Equity
69.9B
KRW
Based on the financial report for Dec 31, 2025, iNtRON Biotechnology Inc's Total Equity amounts to 69.9B KRW.
What is iNtRON Biotechnology Inc's Total Equity growth rate?
Total Equity CAGR 10Y
7%
Over the last year, the Total Equity growth was -17%. The average annual Total Equity growth rates for iNtRON Biotechnology Inc have been -13% over the past three years , -4% over the past five years , and 7% over the past ten years .
